Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Broutier

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cell Death & Disease|January 25, 2020
Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signalingElodie Roger, Sylvie Martel, Adrien Bertrand-Chapel, et al.
Elife|October 7, 2024
BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomasPaul Huchede, Swann Meyer, Clément Berthelot, et al.
Nature Medicine|November 14, 2017
Human primary liver cancer-derived organoid cultures for disease modeling and drug screeningLaura Broutier, Gianmarco Mastrogiovanni, Monique Ma Verstegen, et al.
Research Square|February 6, 2026
Dysregulation of human ClpP using small molecules with piperazine-based scaffold for diffuse intrinsic pontine glioma therapy validated by patient-derived tumor organoidsAntonio Scilimati, Morena Miciaccia, Domenico Armenise, et al.
Neuro-Oncology|January 10, 2025
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacologyClémence Deligne, Arthur Tourbez, Flavie Bénard, et al.
Journal of Medicinal Chemistry|July 8, 2026
Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor OrganoidsMorena Miciaccia, Domenico Armenise, Olga Maria Baldelli, et al.
Cell Reports. Medicine|December 20, 2023
Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducersClara Savary, Léa Luciana, Paul Huchedé, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cell Death & Disease|January 25, 2020
Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signalingElodie Roger, Sylvie Martel, Adrien Bertrand-Chapel, et al.
Elife|October 7, 2024
BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomasPaul Huchede, Swann Meyer, Clément Berthelot, et al.
Nature Medicine|November 14, 2017
Human primary liver cancer-derived organoid cultures for disease modeling and drug screeningLaura Broutier, Gianmarco Mastrogiovanni, Monique Ma Verstegen, et al.
Research Square|February 6, 2026
Dysregulation of human ClpP using small molecules with piperazine-based scaffold for diffuse intrinsic pontine glioma therapy validated by patient-derived tumor organoidsAntonio Scilimati, Morena Miciaccia, Domenico Armenise, et al.
Neuro-Oncology|January 10, 2025
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacologyClémence Deligne, Arthur Tourbez, Flavie Bénard, et al.
Journal of Medicinal Chemistry|July 8, 2026
Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor OrganoidsMorena Miciaccia, Domenico Armenise, Olga Maria Baldelli, et al.
Cell Reports. Medicine|December 20, 2023
Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducersClara Savary, Léa Luciana, Paul Huchedé, et al.
Pageof 2